Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Acute monophasic focal demyelinating diseases of the central nervous system: longitudinal cliniconeuroradiological study of two patients

  • 30 Accesses

Abstract

We report the clinical features and laboratory-instrumental findings in two patients with acute monophasic demyelinating disease with focal clinical expression: one case of incomplete cervical transverse myelitis and one of focal supratentorial encephalitis. We describe the clinical course and evolution of the neuroradiological findings (CT and MRI) and discuss their pathological meaning and diagnostic value.

Sommario

Descriviamo le caratteristiche cliniche e i riscontri laboratoristici-strumentali di due pazienti con malattia demielinizzante acuta monofasica ad espressione clinica focale: un caso di mielite trasversa cervicale incompleta ed uno di encefalite sopratentoriale focale.

Sono illustrati il decorso clinico e l'evoluzione dei reperti neuroradiologici (TAC e RMN), discutendone il significato patologico e l'utilità diagnostica.

This is a preview of subscription content, log in to check access.

References

  1. [1]

    Berman M., Feldman S., Alter M. et al.:Acute transverse myelitis: incidence and etiologic considerations. Neurology 31:966–971, 1981.

  2. [2]

    Durelli L., Cocito D., Riccio A. et al.:High dose intravenous methylprednisolone in the treatment of multiple sclerosis. Neurology 36:238–243, 1986.

  3. [3]

    Ebers G.C., Vinuela F.V., Feasby T., Bass B.:Multifocal CT enhancement in multiple sclerosis. Neurology 34:341–346, 1984.

  4. [4]

    Francis G.S., Antel J.P., Duquette P.:Inflammatory demyelinating diseases of the central nervous system. In: Neurology in Clinical Practice, Bradley G.W., Daroff R.B., Fenichel G.M., Marsden C.D., eds., Butterworth, 1133–1166, 1990.

  5. [5]

    Kermode A.G., Thompson A.J., Tofts P. et al.:Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 113:1477–1489, 1990.

  6. [6]

    Kesserling J., Miller D.H., Robb S.A., et al.:Acute disseminated encephalomyelitis. Brain 113:291–302, 1990.

  7. [7]

    Miller D.H., Rudge P., Johnson, G. et al.:Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 111:927–939, 1988.

  8. [8]

    Pozzilli C., Bernard S., Mansi L. et al.:Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography. J. Neurol. Neurosurg. Psychiatry 51:1058–1062, 1988.

  9. [9]

    Poser C.M.:Disseminated vasculomyelinopathy. Acta Neurol. Scand. 45 (suppl. 37):1–44, 1969.

  10. [10]

    Poser C.M.:Taxonomy and diagnostic parameters in multiple sclerosis. Ann. N.Y. Acad. Sci. 436:233–245, 1985.

  11. [11]

    Poser C.M.:Pathogenesis of multiple sclerosis. Acta Neuropathol. 71:1–10, 1986.

  12. [12]

    Poser C.M.:Magnetic resonance imaging in asymptomatic disseminated vasculomyelinopathy. J. Neurol. Sci. 94:69–77, 1989.

Download references

Author information

Correspondence to Dr. P. Di Bella.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Di Bella, P., Logullo, F., Danni, M. et al. Acute monophasic focal demyelinating diseases of the central nervous system: longitudinal cliniconeuroradiological study of two patients. Ital J Neuro Sci 13, 761–766 (1992). https://doi.org/10.1007/BF02229162

Download citation

Key Words

  • Demyelinating diseases
  • multiple sclerosis
  • MRI